The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 02, 2021

Filed:

Nov. 17, 2015
Applicants:

Jiangsu Hengrui Medicine Co., Ltd., Jiangsu, CN;

Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, CN;

Inventors:

Xiangdong Qu, Shanghai, CN;

Xin Ye, Shanghai, CN;

Qiyue Hu, Shanghai, CN;

Dongbing Cui, Shanghai, CN;

Weikang Tao, Shanghai, CN;

Lianshan Zhang, Shanghai, CN;

Piaoyang Sun, Jiangsu, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/20 (2006.01); C07K 14/54 (2006.01); A61P 35/00 (2006.01); C07K 14/715 (2006.01); C07K 19/00 (2006.01); A61P 37/04 (2006.01); A61P 37/02 (2006.01); A61P 31/00 (2006.01); A61P 17/00 (2006.01); A61P 19/02 (2006.01); A61P 1/00 (2006.01); A61P 29/00 (2006.01); C12N 15/62 (2006.01); A61K 47/64 (2017.01); C07K 16/30 (2006.01);
U.S. Cl.
CPC ...
A61K 38/2086 (2013.01); A61K 38/20 (2013.01); A61P 1/00 (2018.01); A61P 17/00 (2018.01); A61P 19/02 (2018.01); A61P 29/00 (2018.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); A61P 37/02 (2018.01); A61P 37/04 (2018.01); C07K 14/5443 (2013.01); C07K 14/7155 (2013.01); C07K 19/00 (2013.01); C12N 15/62 (2013.01); A61K 47/642 (2017.08); A61K 2300/00 (2013.01); C07K 16/30 (2013.01); C07K 2319/30 (2013.01);
Abstract

An interleukin 15 (IL-15) protein complex is provided. The IL-15 protein complex includes soluble fusion proteins (I) and (II), wherein the fusion protein (I) is an IL-15 polypeptide or a functional fragment thereof, and the soluble fusion protein (II) is an IL-15Rα polypeptide or a functional fragment thereof. The soluble fusion protein (I) has at least one amino acid residue mutated to a cysteine (Cys) residue, which pairs with a corresponding mutated Cys residue on the soluble fusion protein (II), or vice versa, to form one or more disulfide bonds. The IL-15 protein complex can be used for tumor therapy.


Find Patent Forward Citations

Loading…